In 2018, the FDA approved Merck’s drugs Delstrigo and Pifeltro to treat this disease, noting that they caused a surprising positive side effect of lowering cholesterol. It is often treated using a cocktail of protease and integrase inhibitors. Burroughs-Wellcome marketed the first drug used to treat this disease, which is alternately called ZDV or AZT. Maraviroc, a drug used to treat this disease, targets the CCR5 receptor on helper T-cells. Reverse transcriptase inhibitors and antiretrovirals are commonly used to treat, for 10 points, what sexually transmitted disease?
In 2018, the FDA approved Merck’s drugs Delstrigo and Pifeltro to treat this disease, noting that they caused a surprising positive side effect of lowering cholesterol. It is often treated using a cocktail of protease and integrase inhibitors. Burroughs-Wellcome marketed the first drug used to treat this disease, which is alternately called ZDV or AZT. Maraviroc, a drug used to treat this disease, targets the CCR5 receptor on helper T-cells. Reverse transcriptase inhibitors and antiretrovirals are commonly used to treat, for 10 points, what sexually transmitted disease?
In 2018, the FDA approved Merck’s drugs Delstrigo and Pifeltro to treat this disease, noting that they caused a surprising positive side effect of lowering cholesterol.